Browsing by Author "Wailagala, Abdullah"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Optimizing Highly Infectious Disease Isolation Unit Management: Experiences From the Infectious Diseases Isolation and Research Unit, Fort Portal, Uganda
    (Disaster Medicine and Public Health Preparedness, 2021) Alum, Susan; Asiimwe, Moses; Kanyomozi, Gerald; Nalikka, Jacqueline; Okwaro, Peace; Migisha, Isabella; Muhindo, Brenda; Wailagala, Abdullah; Okello, Stephen; Blair, Paul; Waitt, Peter; Bhadelia, Nahid; Ayebare, Rodgers; Kwiecien, Antonia; Saunders, David; Lamorde, Mohammed; Kibuuka, Hannah; Clark, Danielle
    Infectious disease outbreaks on the scale of the current coronavirus disease 2019 (COVID-19) pandemic are a new phenomenon in many parts of the world. Many isolation unit designs with corresponding workflow dynamics and personal protective equipment postures have been proposed for each emerging disease at the health facility level, depending on the mode of transmission. However, personnel and resource management at the isolation units for a resilient response will vary by human resource capacity, reporting requirements, and practice setting. This study describes an approach to isolation unit management at a rural Uganda Hospital and shares lessons from the Uganda experience for isolation unit managers in low- and middle-income settings.
  • Thumbnail Image
    Item
    The Potential Teratogenicity Alert for Women Conceiving on Dolutegravir‑Based Regimens: An Assessment of Risk Communication by an Urban HIV Clinic in Uganda and Choices made by Women
    (Drug Safety, 2020) Laker, Eva Agnes Odongpiny; Arinaitwe, Arnold; Owarwo, Noela; Onzia, Annet; Nasasira, Benson; Wailagala, Abdullah; Kalule, Ivan; Anguzu, Godwin; Kiragga, Agnes; Lwanga, Isaac; Castelnuovo, Barbara; Musomba, Rachel; Lamorde, Mohammed
    In May 2018, the World Health Organization and other regulatory authorities released a safety alert for dolutegravir related to a risk of neural tube defects among women exposed to dolutegravir at the time of conception. Models of how drug safety information can be shared effectively in the shortest time are necessary to prevent interruptions of public health programs. We sought to describe an implementation process to inform and support women already on dolutegravir-based regimens at the time of conception to make informed choices following the safety alert of a potential teratogenicity risk. We describe the choices made by women, as well as determine the factors associated with women’s choices to switch off dolutegravir.
  • Thumbnail Image
    Item
    Sudan Virus Disease among Health Care Workers, Uganda, 2022
    (New England Journal of Medicine, 2024-07-17) Wailagala, Abdullah; Kobba, Kenneth; Aanyu-Tumukahebwa, Hellen; Kirenga, Bruce; Wayengera, Misaki
    Infections among health care workers represented a high proportion of cases during the first weeks of the 2022 Ebola outbreak in Uganda.1 This Ebola outbreak, which was caused by Sudan virus, resulted in 19 infections in health care workers among 142 confirmed cases.1 Not only are health care workers vulnerable to infection, but cases that occur early after detection of an Ebola outbreak carry an increased risk of death2 as health systems scramble to set up well-functioning Ebola treatment units. Ethical priority for immediate and quality care of infected health care workers is buttressed by the need to minimize fear, burnout, and strikes among these workers, since such complications could ultimately lead to deaths among patients with or without Ebola disease.